| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-31 RA | HOTAvitag ILA-H82E9 | Biotinylated Human IL-31 RA Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| IL-31 RA | Mouse IL-31 RA Protein, Fc Tag (BLI verified) | Mouse | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | ||
| IL-31 RA | HOT ILA-H525b | Cynomolgus IL-31 RA Protein, Fc Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $395.00 100ug | |
| IL-31 RA | Human IL-31 RA Protein, His Tag, low endotoxin (Mass Spec & MALS & SPR verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $435.00 100ug | ||
| IL-31 RA | Human IL-31 RA Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $415.00 100ug | ||
| IL-31 RA | Avitag ILA-H82F6 | Biotinylated Human IL-31 RA Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nemolizumab | CD-14152; CIM-331; M 5250; M 5250B | Approved | Chugai Pharmaceutical Co Ltd | Mitchga, Nemluvio | Japan | Dermatitis, Atopic; Pruritus | Maruho Co Ltd | 2022-03-28 | Dermatitis, Atopic; Prurigo; Prurigo Nodularis; Pruritus; Scleroderma, Systemic | Details |